RSS-Feed abonnieren
DOI: 10.1055/s-0031-1297167
Thrombosis in Children
Publikationsverlauf
Publikationsdatum:
20. Dezember 2011 (online)

ABSTRACT
Thrombosis in children is becoming more prevalent due to increased awareness of these issues in the pediatric population and advances in medicine. Management of affected children are challenging due to differences in their hemostatic system compared with adults. Prospective, controlled trials for management/treatment of children with thrombosis are lacking. Many of the available guidelines for treatment of thrombosis in children are extrapolated from adult data and do not account for the uniqueness of the pediatric hemostatic system, although more research and data are becoming available. This review will focus on children over 1 year of age, including adolescents, looking at the etiology of thrombosis, diagnosis, management options, and any associated complications in this pediatric population.
KEYWORDS
Thrombosis - pediatrics - anticoagulation
REFERENCES
- 1
Andrew M, David M, Adams M et al..
Venous thromboembolic complications (VTE) in children: first analyses of the Canadian
Registry of VTE.
Blood.
1994;
83
(5)
1251-1257
MissingFormLabel
- 2
Male C, Chait P, Ginsberg J S et al..
Comparison of venography and ultrasound for the diagnosis of asymptomatic deep vein
thrombosis in the upper body in children: results of the PARKAA study. Prophylactic
Antithrombin Replacement in Kids with ALL treated with Asparaginase.
Thromb Haemost.
2002;
87
(4)
593-598
MissingFormLabel
- 3
Fraser D G, Moody A R, Davidson I R, Martel A L, Morgan P S.
Deep venous thrombosis: diagnosis by using venous enhanced subtracted peak arterial
MR venography versus conventional venography.
Radiology.
2003;
226
(3)
812-820
MissingFormLabel
- 4
Shankar K R, Abernethy L J, Das K S et al..
Magnetic resonance venography in assessing venous patency after multiple venous catheters.
J Pediatr Surg.
2002;
37
(2)
175-179
MissingFormLabel
- 5
Biss T T, Brandão L R, Kahr W H, Chan A K, Williams S.
Clinical features and outcome of pulmonary embolism in children.
Br J Haematol.
2008;
142
(5)
808-818
MissingFormLabel
- 6
Massicotte M P, Dix D, Monagle P, Adams M, Andrew M.
Central venous catheter related thrombosis in children: analysis of the Canadian Registry
of Venous Thromboembolic Complications.
J Pediatr.
1998;
133
(6)
770-776
MissingFormLabel
- 7
Kuhle S, Massicotte P, Chan A et al..
Systemic thromboembolism in children. Data from the 1-800-NO-CLOTS Consultation Service.
Thromb Haemost.
2004;
92
(4)
722-728
MissingFormLabel
- 8
Male C, Foulon D, Hoogendoorn H et al..
Predictive value of persistent versus transient antiphospholipid antibody subtypes
for the risk of thrombotic events in pediatric patients with systemic lupus erythematosus.
Blood.
2005;
106
(13)
4152-4158
MissingFormLabel
- 9
Newall F, Barnes C, Ignjatovic V, Monagle P.
Heparin-induced thrombocytopenia in children.
J Paediatr Child Health.
2003;
39
(4)
289-292
MissingFormLabel
- 10
Saxon B R, Black M D, Edgell D, Noel D, Leaker M T.
Pediatric heparin-induced thrombocytopenia: management with Danaparoid (orgaran).
Ann Thorac Surg.
1999;
68
(3)
1076-1078
MissingFormLabel
- 11
Chan V H, Monagle P, Massicotte P, Chan A K.
Novel paediatric anticoagulants: a review of the current literature.
Blood Coagul Fibrinolysis.
2010;
21
(2)
144-151
MissingFormLabel
- 12
van Ommen C H, Heijboer H, van den Dool E J, Hutten B A, Peters M.
Pediatric venous thromboembolic disease in one single center: congenital prothrombotic
disorders and the clinical outcome.
J Thromb Haemost.
2003;
1
(12)
2516-2522
MissingFormLabel
- 13
Young G, Albisetti M, Bonduel M et al..
Impact of inherited thrombophilia on venous thromboembolism in children: a systematic
review and meta-analysis of observational studies.
Circulation.
2008;
118
(13)
1373-1382
MissingFormLabel
- 14
Revel-Vilk S, Chan A, Bauman M, Massicotte P.
Prothrombotic conditions in an unselected cohort of children with venous thromboembolic
disease.
J Thromb Haemost.
2003;
1
(5)
915-921
MissingFormLabel
- 15
Schneppenheim R, Greiner J.
Thrombosis in infants and children.
Hematology (Am Soc Hematol Educ Program).
2006;
(1)
86-96
MissingFormLabel
- 16
Nowak-Göttl U, Sträter R, Heinecke A et al..
Lipoprotein (a) and genetic polymorphisms of clotting factor V, prothrombin, and methylenetetrahydrofolate
reductase are risk factors of spontaneous ischemic stroke in childhood.
Blood.
1999;
94
(11)
3678-3682
MissingFormLabel
- 17
Aschka I, Aumann V, Bergmann F et al..
Prevalence of factor V Leiden in children with thrombo-embolism.
Eur J Pediatr.
1996;
155
(12)
1009-1014
MissingFormLabel
- 18
Nowak-Göttl U, Junker R, Hartmeier M et al..
Increased lipoprotein(a) is an important risk factor for venous thromboembolism in
childhood.
Circulation.
1999;
100
(7)
743-748
MissingFormLabel
- 19
Raffini L, Raybagkar D, Cahill A M, Kaye R, Blumenstein M, Manno C.
May-Thurner syndrome (iliac vein compression) and thrombosis in adolescents.
Pediatr Blood Cancer.
2006;
47
(6)
834-838
MissingFormLabel
- 20
Monagle P, Chalmers E, Chan A American College of Chest Physicians et al.
Antithrombotic therapy in neonates and children: American College of Chest Physicians
Evidence-Based Clinical Practice Guidelines (8th Edition).
Chest.
2008;
133
(6, Suppl)
887S-968S
MissingFormLabel
- 21
Streif W, Andrew M, Marzinotto V et al..
Analysis of warfarin therapy in pediatric patients: a prospective cohort study of
319 patients.
Blood.
1999;
94
(9)
3007-3014
MissingFormLabel
- 22
Hirsh J.
Heparin.
N Engl J Med.
1991;
324
(22)
1565-1574
MissingFormLabel
- 23
Newall F, Ignjatovic V, Johnston L et al..
Age is a determinant factor for measures of concentration and effect in children requiring
unfractionated heparin.
Thromb Haemost.
2010;
103
(5)
1085-1090
MissingFormLabel
- 24
Chan A K, Black L, Ing C, Brandão L R, Williams S.
Utility of aPTT in monitoring unfractionated heparin in children.
Thromb Res.
2008;
122
(1)
135-136
MissingFormLabel
- 25
Raschke R A, Reilly B M, Guidry J R, Fontana J R, Srinivas S.
The weight-based heparin dosing nomogram compared with a “standard care” nomogram.
A randomized controlled trial.
Ann Intern Med.
1993;
119
(9)
874-881
MissingFormLabel
- 26
Avioli L V.
Heparin-induced osteopenia: an appraisal.
Adv Exp Med Biol.
1975;
52
375-387
MissingFormLabel
- 27
Kuhle S, Eulmesekian P, Kavanagh B, Massicotte P, Vegh P, Mitchell L G.
A clinically significant incidence of bleeding in critically ill children receiving
therapeutic doses of unfractionated heparin: a prospective cohort study.
Haematologica.
2007;
92
(2)
244-247
MissingFormLabel
- 28
Schmugge M, Risch L, Huber A R, Benn A, Fischer J E.
Heparin-induced thrombocytopenia-associated thrombosis in pediatric intensive care
patients.
Pediatrics.
2002;
109
(1)
E10
MissingFormLabel
- 29
Crowther M A, Berry L R, Monagle P T, Chan A K.
Mechanisms responsible for the failure of protamine to inactivate low-molecular-weight
heparin.
Br J Haematol.
2002;
116
(1)
178-186
MissingFormLabel
- 30
Malowany J I, Monagle P, Knoppert D C Canadian Paediatric Thrombosis and Hemostasis Network et al.
Enoxaparin for neonatal thrombosis: a call for a higher dose for neonates.
Thromb Res.
2008;
122
(6)
826-830
MissingFormLabel
- 31
O'Brien S H, Lee H, Ritchey A K.
Once-daily enoxaparin in pediatric thromboembolism: a dose finding and pharmacodynamics/pharmacokinetics
study.
J Thromb Haemost.
2007;
5
(9)
1985-1987
MissingFormLabel
- 32
Baglin T, Barrowcliffe T W, Cohen A, Greaves M. British Committee for Standards in Haematology .
Guidelines on the use and monitoring of heparin.
Br J Haematol.
2006;
133
(1)
19-34
MissingFormLabel
- 33
Kuhle S, Massicotte P, Dinyari M et al..
Dose-finding and pharmacokinetics of therapeutic doses of tinzaparin in pediatric
patients with thromboembolic events.
Thromb Haemost.
2005;
94
(6)
1164-1171
MissingFormLabel
- 34
Massicotte P, Adams M, Marzinotto V, Brooker L A, Andrew M.
Low-molecular-weight heparin in pediatric patients with thrombotic disease: a dose
finding study.
J Pediatr.
1996;
128
(3)
313-318
MissingFormLabel
- 35
Garcia D, Libby E, Crowther M A.
The new oral anticoagulants.
Blood.
2010;
115
(1)
15-20
MissingFormLabel
- 36
Goldenberg N A, Durham J D, Knapp-Clevenger R, Manco-Johnson M J.
A thrombolytic regimen for high-risk deep venous thrombosis may substantially reduce
the risk of postthrombotic syndrome in children.
Blood.
2007;
110
(1)
45-53
MissingFormLabel
- 37
Yee D L, Chan A K, Williams S, Goldenberg N A, Massicotte M P, Raffini L J.
Varied opinions on thrombolysis for venous thromboembolism in infants and children:
findings from a survey of pediatric hematology-oncology specialists.
Pediatr Blood Cancer.
2009;
53
(6)
960-966
MissingFormLabel
- 38
Raffini L, Cahill A M, Hellinger J, Manno C.
A prospective observational study of IVC filters in pediatric patients.
Pediatr Blood Cancer.
2008;
51
(4)
517-520
MissingFormLabel
- 39
Cook A, Shackford S, Osler T, Rogers F, Sartorelli K, Littenberg B.
Use of vena cava filters in pediatric trauma patients: data from the National Trauma
Data Bank.
J Trauma.
2005;
59
(5)
1114-1120
MissingFormLabel
- 40
Greenfield L J, Proctor M C.
Thromboembolism: prevention and treatment with vena cava filters.
Semin Arthroplasty.
1992;
3
(2)
123-127
MissingFormLabel
- 41
Poon W L, Luk S H, Yam K Y, Lee A C.
Mechanical thrombectomy in inferior vena cava thrombosis after caval filter placement:
a report of three cases.
Cardiovasc Intervent Radiol.
2002;
25
(5)
440-443
MissingFormLabel
- 42
Bogue C O, John P R, Connolly B L, Rea D J, Amaral J G.
Symptomatic caval penetration by a Celect inferior vena cava filter.
Pediatr Radiol.
2009;
39
(10)
1110-1113
MissingFormLabel
- 43
Cahn M D, Rohrer M J, Martella M B, Cutler B S.
Long-term follow-up of Greenfield inferior vena cava filter placement in children.
J Vasc Surg.
2001;
34
(5)
820-825
MissingFormLabel
- 44
Prandoni P, Villalta S, Polistena P, Bernardi E, Cogo A, Girolami A.
Symptomatic deep-vein thrombosis and the post-thrombotic syndrome.
Haematologica.
1995;
80
(2, Suppl)
42-48
MissingFormLabel
- 45
Goldenberg N A, Donadini M P, Kahn S R et al..
Post-thrombotic syndrome in children: a systematic review of frequency of occurrence,
validity of outcome measures, and prognostic factors.
Haematologica.
2010;
95
(11)
1952-1959
MissingFormLabel
- 46
Monagle P, Adams M, Mahoney M et al..
Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood
Thrombophilia Registry.
Pediatr Res.
2000;
47
(6)
763-766
MissingFormLabel
- 47
Kuhle S, Koloshuk B, Marzinotto V et al..
A cross-sectional study evaluating post-thrombotic syndrome in children.
Thromb Res.
2003;
111
(4-5)
227-233
MissingFormLabel
- 48
van Ommen C H, Ottenkamp J, Lam J et al..
The risk of postthrombotic syndrome in children with congenital heart disease.
J Pediatr.
2002;
141
(4)
582-586
MissingFormLabel
- 49
Goldenberg N A, Knapp-Clevenger R, Manco-Johnson M J. Mountain States Regional Thrombophilia Group .
Elevated plasma factor VIII and D-dimer levels as predictors of poor outcomes of thrombosis
in children.
N Engl J Med.
2004;
351
(11)
1081-1088
MissingFormLabel
- 50
Baglin T.
Value of D-dimer testing to decide duration of anticoagulation after deep vein thrombosis:
not yet.
J Thromb Haemost.
2006;
4
(12)
2530-2532
MissingFormLabel
Christine A. MacartneyM.B. D.C.H. M.R.C.P. F.R.C.Path.
Department of Paediatric Haematology, Royal Belfast Hospital for Sick Children, Falls
Road
Belfast BT12 6BE, Northern Ireland, United Kingdom
eMail: christine.macartney@belfasttrust.hscni.net